Jim Simons Myriad Genetics Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 448,374 shares of MYGN stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

448,374

Previous 249,774 79.51%

Holding current value

$3.62 Million

Previous $2.22 Million 7.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$3.84 - $8.84 $762,624 - $1.76 Million	198,600 Added 79.51%	448,374 $2.38 Million
Q1 2025 May 14, 2025	SELL	$8.87 - $14.98 $3.86 Million - $6.52 Million	-435,100 Reduced 63.53%	249,774 $2.22 Million
Q4 2024 Feb 13, 2025	BUY	$13.17 - $27.03 $4.21 Million - $8.64 Million	319,500 Added 87.44%	684,874 $9.39 Million
Q3 2024 Nov 13, 2024	BUY	$23.97 - $28.6 $8.76 Million - $10.4 Million	365,374 New	365,374 $10 Million
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $2.25 Million - $3.25 Million	-154,800 Reduced 91.18%	14,974 $217,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $1.39 Million - $2.13 Million	76,574 Added 82.16%	169,774 $3.24 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $37,407 - $58,851	-2,274 Reduced 2.38%	93,200 $1.69 Million
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $1.3 Million - $1.61 Million	57,500 Added 151.42%	95,474 $2.41 Million
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $4.19 Million - $5.66 Million	-173,600 Reduced 82.05%	37,974 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $4.19 Million - $5.13 Million	139,900 Added 195.19%	211,574 $6.83 Million
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $1.82 Million - $2.34 Million	71,674 New	71,674 $2.19 Million
Q1 2021 May 13, 2021	SELL	$19.92 - $31.6 $985,860 - $1.56 Million	-49,491 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$12.16 - $19.77 $711,153 - $1.16 Million	-58,483 Reduced 54.16%	49,491 $979,000
Q3 2020 Nov 13, 2020	BUY	$11.25 - $14.75 $629,707 - $825,616	55,974 Added 107.64%	107,974 $1.41 Million
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $555,880 - $857,479	52,000 New	52,000 $590,000
Q1 2020 May 14, 2020	SELL	$9.78 - $29.53 $937,901 - $2.83 Million	-95,900 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$20.93 - $35.1 $2.01 Million - $3.37 Million	95,900 New	95,900 $2.61 Million

Others Institutions Holding MYGN

# of Institutions

234

Shares Held

95.2M

Call Options Held

460K

Put Options Held

14.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $652M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account